Healthcare -
Biotechnology - NASDAQ - US
$ 7.9
0.381 %
$ 1.64 B
Market Cap
-12.95
P/E
BCRX - STOCK-BASED COMPENSATION
Stock-based Compensation BCRX - BioCryst Pharmaceuticals, Inc.
55.6 M
LAST VALUE
26.71%
2 YEAR CAGR
42.71%
5 YEAR CAGR
28.97%
10 YEAR CAGR